Management strategies for POSEIDON patients with poor ovarian response to ovarian stimulation: а literature review
Open Access
- 27 May 2024
- journal article
- review article
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 73 (2) , 119-128
Abstract
A poor ovarian response to ovarian stimulation is a factor that significantly reduces the effectiveness of in vitro fertilization programs. Managing these patients remains an unresolved issue in assisted reproductive technology programs. The difficulties are largely determined by the heterogeneity of groups of patients with a poor ovarian response and the need for a personalized approach to ovarian stimulation. This review covers the data from the global literature on the management tactics of patients with a poor ovarian response according to the POSEIDON classification, with the aim of increasing the quantity and quality of retrieved oocytes and clinical pregnancy rates.Keywords
This publication has 50 references indexed in Scilit:
- Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserveJournal of Assisted Reproduction and Genetics, 2017
- The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian responseJournal of Assisted Reproduction and Genetics, 2017
- Ovarian stimulation in the luteal phase: systematic review and meta-analysisJournal of Assisted Reproduction and Genetics, 2016
- Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilizationFertility and Sterility, 2013
- A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transferFertility and Sterility, 2012
- Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markersFertility and Sterility, 2012
- Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trialFertility and Sterility, 2011
- Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization/intracytoplasmic sperm injectionFertility and Sterility, 2009
- Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization–intracytoplasmic sperm injection patientsFertility and Sterility, 2008
- A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilizationFertility and Sterility, 2004